DEPIXUS

In News

New Study Demonstrates Power of Depixus’ Scalable Single Molecule Interactomics Platform to Accelerate RNA-Targeted Drug Development - BioSpace

BioSpace - Sep 25, 2024

Depixus wins SLAS2024 Ignite Award for MAGNA™ technology - Business Wire

Business Wire - Feb 12, 2024

Daiichi Sankyo taps Depixus to speed RNA drug discovery - pharmaphorum.com

pharmaphorum.com - Dec 13, 2023

The biotech bi-weekly: sequencing costs slashed again, biomolecular interactions measured by the thousands and a single-cell picking platform for lipid profiles validated - biotechniques.com

biotechniques.com - Nov 06, 2024

CoNAN projects: new generation of microchip-based tools for genetic analysis - eic.ec.europa.eu

eic.ec.europa.eu - Sep 05, 2023

Depixus Unveils MAGNA One: World’s First Laboratory Instrument for Analyzing Individual Biomolecular Interactions at Scale - BioSpace

BioSpace - Sep 30, 2024

Depixus to showcase unique single molecule technology solving the hit-to-lead challenge in RNA-targeted drug discovery at upcoming Discovery on Target Conference - Business Wire

Business Wire - Sep 20, 2023

SLAS Life Sciences and Technology Awards announced - EurekAlert!

EurekAlert! - Feb 14, 2024

Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology - BioSpace

BioSpace - Jan 11, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment